Research & KnowledgeEvent: August 31, 2026
DeepWork Capital reported that Astrocyte Pharmaceuticals received an NIH grant to test AST-004 in substance use disorders alongside the Oklahoma Medical Research Foundation and UT San Antonio.
Published
Signal category
Research & Knowledge
Quote
“Astrocyte Pharmaceuticals received an NIH grant to test AST-004 in substance use disorders, alongside the Oklahoma Medical Research Foundation and UT San Antonio”
— DeepWork Capital team
Company
DeepWork Capital
Venture Capital for Florida
- Industry
- Financial Services
- Location
- Orlando, US
- Company size
- 17 employees
DeepWork Capital, previously known as FAN Fund, invests professionally managed committed venture capital in growth-oriented early-stage companies in the technology and life science sectors in Florida and surrounding areas. The Firm prefers to take a lead or co-lead investor role while working closely with other investment groups, and takes a hands-on approach with its portfolio companies.
Founded 2015